PropThink: Hope For LLY's Alzheimer's Drug Remains Alive; Stock Will Reflect Optimism
Aug 25, 2012 | Posted by: roboblogger | Full story: PR-inside.com
Eli Lilly & Co. announced this morning that its potential treatment to slow the onset of Alzheimer's Disease, solanezumab, showed favorable effects in its Phase III clinical program.
Add your comments below
|Smucker Co. adds Canadian brand to growing port... (Mar '08)||Mar '08||Loren||3|